| Bioactivity | 6-Dehydronandrolone acetate is a starting material for synthesis of Fulvestrant. Fulvestrant is an estrogen receptor antagonist that can be used for the research of breast cancer[1]. |
| Invitro | Fulvestrant can be synthesized in four steps (35% overall yield) from 6-Dehydronandrolone acetate[1]. |
| Name | 6-Dehydronandrolone acetate |
| CAS | 2590-41-2 |
| Formula | C20H26O3 |
| Molar Mass | 314.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Caprioglio D, et, al. An alternative synthesis of the breast cancer drug fulvestrant (Faslodex®): catalyst control over C-C bond formation. Chem Commun (Camb). 2015 Oct 14;51(80):14866-8. |
6-Dehydronandrolone acetate
CAS: 2590-41-2 F: C20H26O3 W: 314.42
6-Dehydronandrolone acetate is a starting material for synthesis of Fulvestrant. Fulvestrant is an estrogen receptor ant
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.